title: Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity.
abstract: Nocloprost (9 beta-chloro-16,16-dimethyl prostaglandin E2 (PGE2)) was examined for gastroprotective and ulcer-healing activity and compared to 16,16-dimethyl PGE2 (dmPGE) in rats. Nocloprost given intragastrically (i.g.) at various doses (0.01-10 micrograms/kg) 30 min before 100% ethanol, acidified aspirin (ASA), acidified taurocholate, water immersion, or restraint stress dose dependently prevented the formation of gastric lesions, the ID50 values being 0.25, 0.58, 0.06 and 0.12 micrograms/kg, respectively. The gastroprotection provided by nocloprost given i.g. was somewhat enhanced by the presence of acid in the stomach and was reduced by inhibition of gastric acid secretion. Nocloprost given s.c. also showed protective activity against ethanol damage but was ineffective when applied intraduodenally. The protective effect of nocloprost lasted about 8 h whereas that induced by dmPGE lasted 6 h. Nocloprost (0.01-100 micrograms/kg) given i.g. failed to affect gastric acid secretion or intestinal secretion (enteropooling) but prevented the increased gastroduodenal alkaline secretion. Nocloprost alone caused only a transient increase in the mucosal blood flow but prevented the fall in blood flow caused by 100% ethanol. [3H]Nocloprost was absorbed from the small intestine but was then taken up and metabolized by the liver and excreted into the bile so that very little reached the systemic circulation in an unchanged form. Nocloprost, unlike dmPGE, accelerated the healing of chronic gastric ulcerations and enhanced mucosal growth. We conclude that nocloprost is a locally active PGE2 analog with high cytoprotective and ulcer-healing efficacy.
authors.affiliation: Institute of Physiology, Academy of Medicine, Kraków, Poland.
authors.forename: S J
authors.initials: SJ
authors.lastname: Konturek
authors.forename: T
authors.initials: T
authors.lastname: Brzozowski
authors.forename: D
authors.initials: D
authors.lastname: Drozdowicz
authors.forename: E
authors.initials: E
authors.lastname: Krzyzek
authors.forename: J
authors.initials: J
authors.lastname: Garlicki
authors.forename: J
authors.initials: J
authors.lastname: Majka
authors.forename: A
authors.initials: A
authors.lastname: Dembinski
authors.forename: J
authors.initials: J
authors.lastname: Stachura
authors.forename: I
authors.initials: I
authors.lastname: Amon
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents; D004386:Duodenum / Q000187:drug effects; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010434:Pepsin A / Q000378:metabolism; D011461:Prostaglandins F, Synthetic / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012039:Regional Blood Flow / Q000187:drug effects; D013276:Stomach Ulcer / Q000209:etiology / Q000503:physiopathology; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D000897:Anti-Ulcer Agents; D011461:Prostaglandins F, Synthetic; D014665:Vasodilator Agents; C048895:nocloprost; D010434:Pepsin A